(a) Schematic representation of the PCR-based screening of GSΔ44 deletion: the region between exons 43 and 45 was divided into 10 regions of approximately the same length and two primers were designed at the boundaries of each region (amplicons A-I). Genomic DNA from WT and
GSΔ44 cells was used to test the presence of each amplicon. Since GSΔ44 was previously reported as DMDΔ44 patient, the region between amplicons B and C was further sub-divided into 8 pieces and PCR primers were designed (amplicons 1-7). The resulting amplification pattern defined the deletion of GSΔ44 between amplicons 1 and 3. This region was divided into 8 pieces and primers were designed at the boundaries (amplicons a-g). The resulting amplification pattern defined the deletion of GSΔ44 between amplicons b and g. (b) The region identified as described above was amplified by using primers located externally. The exact length (4064 nt) and position of the deletion were therefore identified by Sanger sequencing and schematized in (c). To obtain pLKO-shCELF2a expressing lentiviral vector the following oligos, designed to contain restriction enzyme-like cleavage ends after annealing, were used: 
Azacytidin treatment
WT and GSΔ44 cells were cultured for 7 days in growth medium containing 4 µM azacitidine.
SGCE was a positive control 4 . Oligonucleotides are listed below. 
